Several brokerages have issued reports on UNH. Morgan Stanley maintained UnitedHealth Group Inc (NYSE:UNH) on Thursday, August 17 with "Overweight" rating. American Registered Invest Advisor Incorporated reported 9,185 shares or 0.71% of all its holdings. Finally, BMO Capital Markets began coverage on shares of UnitedHealth Group in a research note on Monday. Pivotal Research has "Buy" rating and $45 target. Analyst's mean target price for UNH is $210.56 while analysts mean recommendation is 1.50. Of those analysts, 16 rate stock as a Strong Buy, 0 rate it as Hold, and just no analyst rates it as a Moderate Sell.
The company's consensus rating on Reuter's scale remained unchanged from 2.76 to 2.76 during a month. UnitedHealth Group Incorporated (UNH) now trades with a market capitalization of $186.53 Billion. The stock is now moving below its 20-Day Simple Moving Average of -1.71% with a 50-Day Simple Moving Average of -1.64 percent. The total amount of shares outstanding is 968.87 million, giving the company a market capitalization of about 186.53 billion.
UnitedHealth Group Inc (NYSE:UNH) early Tuesday posted solid third quarter earnings results and raised its full-year outlook. The consensus estimate was for EPS of $2.56.
UnitedHealth Group Inc notes that its net margin for the third quarter of 2017 was 4.9%. Braun Stacey Associate reported 1.13% of its portfolio in UnitedHealth Group Inc (NYSE:UNH).
UnitedHealth said net earnings rose 26.3 percent to $2.49 billion, or $2.51 per share, in the third quarter ended September 30. UnitedHealth Group's revenue for the quarter was up 8.7% compared to the same quarter a year ago. They expect $-0.34 earnings per share, up 32.00% or $0.16 from last year's $-0.5 per share.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/10/17/unitedhealth-group-incorporated-unh-shares-sold-by-premier-asset-management-llc.html.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Pivotal Research maintained Liberty Global plc - Class A Ordinary Shares (NASDAQ:LILA) rating on Friday, September 11. This represents a $3.00 dividend on an annualized basis and a yield of 1.55%. The company was initiated on Thursday, April 7 by Barclays Capital. The United Kingdom-based Mondrian Ptnrs Ltd has invested 1.65% in UnitedHealth Group Inc (NYSE:UNH). The stock has "Buy" rating by RBC Capital Markets on Monday, August 21. Following the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The circumstantial evidence specially high/lower types of ownership has a vital gauge for investing research process and it should be done carefully, as rather than offering help in finding value; it can sometimes give false signals and lead an investor astray. The disclosure for this sale can be found here.
Since May 4, 2017, it had 0 insider buys, and 3 insider sales for $10.13 million activity.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of Nova Scotia increased its stake in shares of UnitedHealth Group by 7.8% during the 2nd quarter. The Psagot Investment House Ltd holds 47,440 shares with $3.69M value, down from 51,455 last quarter. UnitedHealth Group had 58 analyst reports since September 2, 2015 according to SRatingsIntel. Kings Point Capital Management increased its position in shares of UnitedHealth Group by 27.9% during the first quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate's stock valued at $29,156,000 after buying an additional 1,254 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of UnitedHealth Group by 3,881.4% in the 2nd quarter. Finally, Mitsubishi UFJ Securities Holdings Co. Factory Mutual Insurance Co. grew its stake in shares of UnitedHealth Group by 20.9% in the second quarter.
Marco Investment Management Llc who had been investing in Unitedhealth Group Inc for a number of months, seems to be less bullish one the $196.05B market cap company. The Firm operates through four divisions: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.